HB Wealth Management, LLC

Position in OGN — Organon & Co.

CIK 1911253 Atlanta, GA

Position in OGN

as of Jun 30, 2026 · filed Jul 29, 2026 Compact

Position Value

$163,319

+$69,079 QoQ

Shares Held

12,062

-23.3% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#249

of 626 holders

Holding Since

Mar 2022

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

HB Wealth Management, LLC holds $274,588,072 across 15 Drug Manufacturers - General names. OGN ranks #15 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	64,452	$77,305,668
2	JNJ	Johnson & Johnson	300,713	$76,372,080
3	ABBV	AbbVie Inc.	142,911	$35,962,124
4	MRK	Merck & Co., Inc.	242,175	$31,119,487
5	AMGN	Amgen Inc	56,408	$20,426,464
6	PFE	Pfizer Inc	350,351	$8,436,452
7	GILD	Gilead Sciences, Inc.	51,132	$6,460,016
8	BMY	Bristol Myers Squibb Co	106,923	$6,160,903

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$163,319	12,062	-23.3%	Shares	Sole	2026-07-29
2026-03-31	$94,240	15,733	+39.1%	Shares	Sole	2026-04-27
2025-12-31	$81,092	11,310	-17.3%	Shares	Sole	2026-01-28
2025-09-30	$146,123	13,682	+25.1%	Shares	Sole	2025-10-23
2025-06-30	$105,889	10,939	-49.6%	Shares	Sole	2025-07-17
2025-03-31	$322,949	21,689	+19.7%	Shares	Sole	2025-05-07
2024-12-31	$270,260	18,114	+64.2%	Shares	Sole	2025-01-15
2024-09-30	$211,061	11,033	-14.0%	Shares	Sole	2024-10-15
2024-06-30	$265,477	12,825	+10.8%	Shares	Sole	2024-07-26
2024-03-31	$217,685	11,579	+45.1%	Shares	Sole	2024-04-30
2022-06-30	$269,325	7,980	+34.4%	Shares	Sole	2022-07-15
2022-03-31	$207,414	5,938	—	Shares	Sole	2022-05-16
No filing history on record for this holder in this stock.